Finding the best lung cancer screening methods for cancer survivors
Optimizing Lung Cancer Screening in Cancer Survivors
This study is looking at the best ways to screen for lung cancer in people who have survived breast, prostate, or colorectal cancer, using a new model to understand how lung cancer develops in these patients, so we can improve their screening and care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10877798 on NIH RePORTER |
What this research studies
This research aims to determine the most effective lung cancer screening strategies specifically for survivors of breast, prostate, and colorectal cancers. By creating a new model called the Multi-Racial and Ethnic Lung Cancer Model (MELCAM), the team will simulate how lung cancer develops and progresses in a diverse group of cancer survivors. The study will evaluate the effectiveness and cost-effectiveness of various screening approaches, addressing the unique needs of this population who are at higher risk for lung cancer due to previous treatments and other factors. The findings could help improve screening practices and outcomes for these patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 65 and older who have previously survived breast, prostate, or colorectal cancer.
Not a fit: Patients who have never been diagnosed with cancer or those with lung cancer who are not cancer survivors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved lung cancer screening protocols that enhance survival rates and quality of life for cancer survivors.
How similar studies have performed: While there is limited data on lung cancer screening specifically for cancer survivors, similar approaches in other areas of cancer research have shown promise in improving patient outcomes.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Wisnivesky, Juan P — Icahn School of Medicine at Mount Sinai
- Study coordinator: Wisnivesky, Juan P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.